Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | Ocumetics Technology Corp: Ocumetics nears first human lens implant | 1 | Stockwatch | ||
Di | Ocumetics Technology Corp: Ocumetics Technology 3,212,462-share private placement | 2 | Stockwatch | ||
Di | Ocumetics Technology Corp.: Ocumetics Achieves Clinical Milestones; Poised for Value-Defining First-in-Human Lens Implantations | 2 | TheNewswire | ||
06.08. | Ocumetics Technology Corp: Ocumetics begins patient recruitment for FIH lens study | 1 | Stockwatch | ||
OCUMETICS TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
05.08. | Ocumetics Technology Corp.: Ocumetics Begins Patient Recruitment for First-In-Human Clinical Study of Accommodating Intraocular Lens | 1 | TheNewswire | ||
31.07. | Ocumetics Technology Corp: Ocumetics wins ethics OK for human lens implant trial | 2 | Stockwatch | ||
30.07. | Ocumetics Technology Corp.: Ocumetics Receives Ethics Committee Approval for First-In-Human Clinical Study of Accommodating Intraocular Lens | 1 | TheNewswire | ||
18.07. | Ocumetics Technology Corp: Ocumetics closes $1.12M first tranche of financing | 2 | Stockwatch | ||
17.07. | Ocumetics Technology Corp.: Ocumetics Announces Completion of First Tranche of Unit Private Placement | 1 | TheNewswire | ||
10.07. | Ocumetics Technology Corp: Ocumetics finishes staff training for intraocular study | 1 | Stockwatch | ||
09.07. | Ocumetics Technology Corp.: Ocumetics Completes Staff Training for First-In-Human Clinical Study of Accommodating Intraocular Lens | 1 | TheNewswire | ||
27.06. | Ocumetics Technology Corp: Ocumetics completes virtual site visit in Mexico City | 2 | Stockwatch | ||
26.06. | Ocumetics Technology Corp.: Ocumetics Completes Virtual Site Initiation for First-In-Human Clinical Study of Accommodating Intraocular Lens | 1 | TheNewswire | ||
25.06. | Ocumetics Technology Corp: Ocumetics prepares for Ocumetics FIH clinical studies | 1 | Stockwatch | ||
24.06. | Ocumetics Technology Corp.: First-In-Human Study of Accommodating Intraocular Lens Set to Begin June 26, 2025 | 1 | TheNewswire | ||
04.06. | Ocumetics Technology Corp: Ocumetics Technology arranges $2.1-million financing | - | Stockwatch | ||
04.06. | Ocumetics Technology Corp.: Ocumetics Announces Private Placement | 1 | TheNewswire | ||
04.06. | Ocumetics Technology Corp: Ocumetics sets June 26 as start date for FIH study | 1 | Stockwatch | ||
03.06. | Northern Dynasty, Ocumetics, Star Copper at 52-Week Highs on News | 44 | Baystreet.ca | ||
03.06. | Ocumetics Technology Corp.: Ocumetics Targets June 26, 2025 for Commencement of its First in Human Study | 1 | TheNewswire |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PRIVIA HEALTH GROUP | 21,020 | +1,50 % | Privia Health Group, Inc.: Privia Health Reports Second Quarter 2025 Financial Results | Very Strong First Half Performance Across All Key Operating and Financial MetricsImplemented Providers +13.8% and Practice Collections +18.5% compared to 2Q'24Guidance Raised to Above High End of... ► Artikel lesen | |
HEARTFLOW | 33,240 | 0,00 % | Heartflow, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares | MOUNTAIN VIEW, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the closing of its... ► Artikel lesen | |
GENEDX | 123,14 | 0,00 % | Rackspace US, Inc.: Rackspace Technology und Sema4.ai stellen die erste skalierbare KI-Agent-Lösung für Unternehmen vor | Die unternehmensgerechte Lösung schließt die Lücke zwischen KI-Experimenten und umfassender TransformationSAN ANTONIO, June 18, 2025®) und die Anwendungsmanagement-Expertise von Rackspace mit der fortschrittlichen... ► Artikel lesen | |
AVEANNA HEALTHCARE | 7,150 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2025 Outlook | Second Quarter Revenue was $589.6 million, a 16.8% increase over the prior year periodSecond Quarter Net income was $27.0 million, a 94.3% increase over the prior year periodAdjusted EBITDA for Q2... ► Artikel lesen | |
UNITEDHEALTH | 235,90 | +1,51 % | UnitedHealth: Jetzt ist Einstiegszeit! | Der US-amerikanische Gesundheitskonzern UnitedHealth Group befindet sich in einem spannenden Spannungsfeld zwischen steigenden Gesundheitskosten und innovativen Kostensenkungsstrategien. Anstatt diese... ► Artikel lesen | |
RESHAPE LIFESCIENCES | 3,180 | 0,00 % | Vyome Therapeutics Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND | Effective as of Commencement of Trading on August 15, 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vyome Therapeutics, Inc., a clinical-stage healthcare company targeting immuno-inflammatory and rare... ► Artikel lesen | |
FRESENIUS | 45,850 | +0,61 % | DEUTSCHE BANK RESEARCH stuft Fresenius SE auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Fresenius auf "Buy" mit einem Kursziel von 52 Euro belassen. Der Gesundheitskonzern bleibe ein "Top Pick", schrieb Falko... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 22,390 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
LIFESTANCE HEALTH GROUP | 5,170 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Second Quarter 2025 Results | SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 14,750 | +0,75 % | Alignment Healthcare Reports Second Quarter 2025 Results; Raises Full-Year Outlook Across All Key Metrics | Reports total revenue of $1.0 billion in Q2 and 223,700 health plan members as of June 30, up 49.0% and 27.8% year-over-year respectively Surpasses high-end of Q2 guidance across all key metrics:... ► Artikel lesen | |
PAUL HARTMANN | 233,00 | -4,90 % | Januar bis Juni 2025: PAUL HARTMANN behauptet sich in herausforderndem Marktumfeld | Heidenheim (ots) - - Umsatzerlöse steigen auf 1.214,0 Mio. EUR, organisches Umsatzwachstum von 1,6 % - Bereinigtes EBITDA liegt bei 125,8 Mio. EUR, bereinigte EBITDA-Rendite bei 10,4 % - Transformationsprogramm... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 42,710 | +0,40 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung gemäß Artikel 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014 und Artikel 2 Abs. 1 der Delegierten... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 40,370 | 0,00 % | PROCEPT BioRobotics Corp - 10-Q, Quarterly Report | ||
ECKERT & ZIEGLER | 19,400 | -0,67 % | EQS-News: Eckert & Ziegler SE: Erneute Ergebnissteigerung im ersten Halbjahr 2025 | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Halbjahresergebnis/Halbjahresbericht
Eckert & Ziegler: Erneute Ergebnissteigerung im ersten Halbjahr 2025
08.08.2025 / 07:45... ► Artikel lesen | |
PROGYNY | 23,060 | 0,00 % | Progyny, Inc. Announces Second Quarter 2025 Results | Reports Record Revenue of $332.9 Million, Reflecting 9.5% GrowthGenerates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance... ► Artikel lesen |